Comparative Efficacy of Radiofrequency and Laser Ablation for the Treatment of Benign Thyroid Nodules: Systematic Review Including Traditional Pooling and Bayesian Network Meta-analysis
Overview
Authors
Affiliations
Purpose: To compare the efficacy of radiofrequency ablation (RFA) and laser ablation (LA) for treatment of benign solid thyroid nodules, using a systematic review including traditional pooling and Bayesian network meta-analysis.
Materials And Methods: A comprehensive literature search in PubMed-MEDLINE, EMBASE, and the Cochrane Library databases identified prospective studies evaluating the percentage mean change [absolute mean change (mL)] in nodule volume after RFA or LA. Studies from January 1, 2000, to November 1, 2013, were included. Review of 128 potential papers, including a full-text review of 33, identified 10 eligible papers covering a total of 184 patients for meta-analysis. The percentage mean change [absolute mean change] in nodule volume over a 6-month follow-up was compared between RFA and LA.
Results: Based on the traditional frequentist approach, the pooled percentage mean changes (95% confidence interval) of RFA and LA were 76.1% (70.1-82.1) and 49.9% (41.4-58.5), respectively, and the pooled absolute mean changes (95% confidence interval) of RFA and LA were 8.9 mL (6.6-11.2) and 5.2 mL (4.3-6.1), respectively. Based on the Bayesian network meta-analysis, RFA achieved a larger pooled percentage mean change (95% credible interval) and absolute mean change (95% credible interval) compared to LA [77.8% (67.7-88.0) vs 49.5% (26.7-72.4), and 9.2 mL (5.8-11.9) vs 5.3 mL (2.1-8.5), respectively]. The RFA group has the highest probability of having the most efficacious treatment (98.7%). There were no major complications after either RFA or LA.
Conclusions: RFA appears to be superior to LA in reducing benign solid thyroid nodule volume, despite the smaller number of treatment sessions without major side effects.
Li M, Jiang H, Wang Y, Li F Asian Biomed (Res Rev News). 2024; 18(6):287-296.
PMID: 39697216 PMC: 11650422. DOI: 10.2478/abm-2024-0036.
Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.
Chan W, Chiang P, Lin A, Chang Y, Lin W Ultrasonography. 2024; 43(6):395-406.
PMID: 39397446 PMC: 11532522. DOI: 10.14366/usg.24083.
Wang M, Yang S, Yang L, Lin N Ther Clin Risk Manag. 2024; 20:515-528.
PMID: 39193477 PMC: 11348989. DOI: 10.2147/TCRM.S458576.
Sun X, Chen J, Zou Y, Lei J, Liu W Medicine (Baltimore). 2024; 103(18):e38014.
PMID: 38701262 PMC: 11062690. DOI: 10.1097/MD.0000000000038014.
Radiofrequency ablation of thyroid nodules: a clinical review of treatment complications.
Issa P, Cironi K, Rezvani L, Kandil E Gland Surg. 2024; 13(1):77-86.
PMID: 38323235 PMC: 10839694. DOI: 10.21037/gs-22-539.